Top Markets
#1 Orochi Network Orochi Network +75.87%
#2 Bitway Bitway +26.98%
#3 Audiera Audiera +24.63%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +18.60%
#5 Pharos Pharos +15.97%
#6 SOON SOON +15.75%
#7 Cheems Token Cheems Token +14.21%
#8 Taiko Taiko +13.85%
#9 Manadia Manadia +13.47%
#10 ROLL ROLL +13.27%
Coin of the day
Orochi Network Orochi Network
設定
言語
日本
通貨
USD
テーマ
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
株式のランク #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
株価
$50.93
時価総額
$226.32B
変化（1日）
2.54%
変化（1年）
-26.19%
国
DK
取引 Novo Nordisk A/S (NVO)

カテゴリー

Healthcare
Novo Nordisk A/S（NVO）のP/B比率
July 2026 時点のP/B比率 TTM: 6.99
Novo Nordisk A/S の最新の財務報告および株価によると、現在のP/B比率（TTM）は 6.99 です。2024 年末時点でのP/B比率は 19.38 でした。
Novo Nordisk A/S の P/B 比率の履歴（2000 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
2026 (TTM) 6.99 -6.12%
2025 7.45 -61.56%
2024 19.38 -34.02%
2023 29.37 15.39%
2022 25.45 6.65%
2021 23.87 51.77%
2020 15.72 -1.35%
2019 15.94 12.22%
2018 14.20 -14.34%
2017 16.58 16.48%
2016 14.23 -34.97%
2015 21.89 29.23%
2014 16.94 35.36%
2013 12.51 -0.67%
2012 12.60 26.42%
2011 9.97 0.88%
2010 9.88 77.44%
2009 5.57 9.91%
2008 5.07 -20.41%
2007 6.36 25.26%
2006 5.08 20.40%
2005 4.22 11.39%
2004 3.79 16.59%
2003 3.25 4.96%
2002 3.10 -47.14%
2001 5.86 -4.54%
2000 6.14 0.00%
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.251 -10.63%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.1715 -68.95%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.065 -41.88%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3009 4.39%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
 34.7575 396.95%
US